We describe an HLA transgenic mouse that acquires fully human TCR mimic antibodies through a proprietary immunization procedure. Beacon on-chips screening and high-throughput binding validation accelerate antibody discovery. Diversified antibody sequences ensure the screening of antibodies with high specificity and high affinity.